Error

Leukemia researchers led by Dr. John Dick have traced the origins of relapse in acute myeloid leukemia (AML) to rare therapy-resistant leukemia stem cells that are already present at diagnosis and before chemotherapy begins. They have also identified two distinct stem-cell like populations from which relapse can arise in different patients in this aggressive cancer […]